Using a Bayesian adaptive phase II trial design to test multiple genetic-marker-directed drugs in the National Lung Matrix Trial
- Billingham, L. (Invited speaker)
- Kristian Brock (Invited speaker)
- Laura Llewellyn (Invited speaker)
- Sanjay Popat (Invited speaker)
- Middleton, G. (Invited speaker)
Activity: Academic and Industrial events › Conference, workshop or symposium